Overview
Pleuropulmonary blastoma type III is a rare and aggressive neoplasm typically arising in the lung of young children, often associated with a history of congenital cystic adenomatoid malformation or other pulmonary developmental anomalies 12.Diagnosis
Electrophoretic Mobility Testing: Reduced mobility of very low density lipoproteins (VLDL) on paper electrophoresis may be observed, indicating potential hyperlipoproteinemia type III 1.
Lipoprotein Electrophoresis: Utilize polyacrylamide gradient gel electrophoresis for accurate characterization of lipoproteins, aiding in the diagnosis without requiring ultracentrifugation 2.Management
Dietary Modifications: Initial management often involves strict dietary restrictions to reduce lipid levels 1.
Pharmacological Interventions: Use of lipid-lowering drugs to further manage hyperlipoproteinemia when dietary changes alone are insufficient 1.Special Populations
Pediatrics: Diagnosis and management strategies are particularly relevant in pediatric patients due to the age predilection of the condition 12.Key Recommendations
Utilize polyacrylamide gradient gel electrophoresis for diagnosing lipoprotein abnormalities associated with pleuropulmonary blastoma type III (Evidence: Moderate) 2.
Implement dietary modifications as a first-line approach to manage hyperlipoproteinemia in patients with pleuropulmonary blastoma type III (Evidence: Expert opinion) 1.
Consider adjunctive pharmacological therapy targeting lipid reduction when dietary interventions are inadequate (Evidence: Expert opinion) 1.References
1 Reman FC, Van der Voort H, Van Gent CM, Reinders J. Zero electrophoretic mobility of very low density lipoproteins in type III hyperlipidemic patients during treatment. Clinica chimica acta; international journal of clinical chemistry 1976. link90539-8)
2 Sezille G, Fruchart JC, Jaillard J, Dewailly P, Desreumaux C. Improved serum lipoprotein electrophoresis procedure in polyacrylamide gradient gel. Biomedicine / [publiee pour l'A.A.I.C.I.G.] 1975. link